Please enable JavaScript to continue using this application.

Compare $RNTX vs $TXTM | Chartloom

Compare

$RNTX vs $TXTM

Rein Therapeutics Inc · Protext Mobility Inc

RNTX

Rein Therapeutics Inc

TXTM

Protext Mobility Inc

Compare $RNTX vs $TXTM

Comparing Rein Therapeutics Inc and Protext Mobility Inc

RNTXRein Therapeutics Inc

TXTMProtext Mobility Inc

RNTXRein Therapeutics Inc

Market cap

$68M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-36.5%

52W performance

-42.9%

FCF yield

-27.7%

TXTMProtext Mobility Inc

Market cap

$65M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

100.0%

52W performance

184.6%

FCF yield

-1.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

RNTX

TXTM

Detailed metrics comparison

RNTX

Rein Therapeutics Inc

TXTM

Protext Mobility Inc

Market Cap

RNTX$68M

TXTM$65M

Enterprise Value

RNTX$59M

TXTM$66M

Price

RNTX$0.79

TXTM$0.01

P/E Ratio

RNTXN/A

TXTMN/A

P/S Ratio

RNTX0.00x

TXTM81,318.79x

EV/Sales

RNTX0.00x

TXTM83,093.29x

EV/EBITDA

RNTX0.00x

TXTM0.00x

P/B Ratio

RNTX1.25x

TXTMN/A

P/FCF Ratio

RNTXN/A

TXTMN/A

EV/FCF

RNTX-3.15x

TXTM-94.20x

PEG Ratio

RNTXN/A

TXTMN/A

Forward P/E (NTM)

RNTXN/A

TXTMN/A

Forward P/S (NTM)

RNTXN/A

TXTMN/A

Revenue (TTM)

RNTX$0

TXTM$800

Revenue Growth (YoY)

RNTXN/A

TXTMN/A

Forward Rev Growth

RNTX113.7%

TXTM0.0%

Gross Margin (TTM)

RNTX0.0%

TXTM87.5%

Operating Margin (TTM)

RNTX0.0%

TXTM0.0%

EBITDA Margin (TTM)

RNTX0.0%

TXTM-128712.5%

Net Margin (TTM)

RNTX0.0%

TXTM-276562.5%

FCF Margin (TTM)

RNTXN/A

TXTM-88212.5%

Net Income (TTM)

RNTX$-50M

TXTM$-2M

FCF (TTM)

RNTX$-19M

TXTM$-706K

EPS (TTM)

RNTX-$0.74

TXTM-$0.01

ROE (TTM)

RNTX-15323.0%

TXTM-940097.1%

ROA (TTM)

RNTX-11700.0%

TXTM-522856.0%

ROIC (TTM)

RNTX-14763.0%

TXTM0.0%

Cash

RNTX$9M

TXTM$700

Debt

RNTX$0

TXTM$1M

Net Cash/Debt

RNTX$9M

TXTM$-1M

Current Ratio (TTM)

RNTX4.27x

TXTM0.00x

Quick Ratio (TTM)

RNTX4.26x

TXTM0.00x

Debt/Equity (TTM)

RNTX0.00x

TXTM0.00x

Debt/Assets (TTM)

RNTX0.0%

TXTM0.0%

Interest Coverage (TTM)

RNTXN/A

TXTMN/A

Net Debt/EBITDA (TTM)

RNTX0.00x

TXTM0.00x

Beta

RNTX1.40

TXTM-3.17

52W Performance

RNTX-42.9%

TXTM184.6%

YTD Performance

RNTX-36.5%

TXTM100.0%

% from 52W High

RNTX-63.6%

TXTM-26.0%

% from 52W Low

RNTX14.4%

TXTM393.3%

Asset Turnover (TTM)

RNTX0.00x

TXTM0.04x

FCF Yield (TTM)

RNTX-27.7%

TXTM-1.1%

Earnings Yield (TTM)

RNTX-73.3%

TXTM-3.4%

Dividend Yield (TTM)

RNTXN/A

TXTMN/A

Rule of 40

RNTX0.0

TXTM-88,212.5

EV/GP/RG

RNTXN/A

TXTMN/A

Ticker research

View RNTX research View TXTM research

Metric	RNTX Rein Therapeutics Inc	TXTM Protext Mobility Inc
Market & Valuation
Market Cap	$68M	$65M
Enterprise Value	$59M	$66M
Price	$0.79	$0.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81,318.79x
EV/Sales	0.00x	83,093.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.25x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-3.15x	-94.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$800
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	113.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	87.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-128712.5%
Net Margin (TTM)	0.0%	-276562.5%
FCF Margin (TTM)	N/A	-88212.5%
Net Income (TTM)	$-50M	$-2M
FCF (TTM)	$-19M	$-706K
EPS (TTM)	-$0.74	-$0.01
ROE (TTM)	-15323.0%	-940097.1%
ROA (TTM)	-11700.0%	-522856.0%
ROIC (TTM)	-14763.0%	0.0%
Financial Health
Cash	$9M	$700
Debt	$0	$1M
Net Cash/Debt	$9M	$-1M
Current Ratio (TTM)	4.27x	0.00x
Quick Ratio (TTM)	4.26x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	-3.17
52W Performance	-42.9%	184.6%
YTD Performance	-36.5%	100.0%
% from 52W High	-63.6%	-26.0%
% from 52W Low	14.4%	393.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-27.7%	-1.1%
Earnings Yield (TTM)	-73.3%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-88,212.5
EV/GP/RG	N/A	N/A
Ticker research	View RNTX research	View TXTM research

Valuation

P/S Ratio

RNTX

0.00x

TXTM

81,318.79x

EV/FCF

TXTM

-94.20x

RNTX

-3.15x

Growth & revenue

Forward Revenue Growth

RNTX

113.7%

TXTM

0.0%

Profitability & performance

Gross Margin

TXTM

87.5%

RNTX

0.0%

ROE

RNTX

-15323.0%

TXTM

-940097.1%

FCF Yield %

TXTM

-1.1%

RNTX

-27.7%

52-Week Performance

TXTM

184.6%

RNTX

-42.9%

Detailed metrics comparison

RNTX

Rein Therapeutics Inc

TXTM

Protext Mobility Inc

Market Cap

RNTX$68M

TXTM$65M

Enterprise Value

RNTX$59M

TXTM$66M

Price

RNTX$0.79

TXTM$0.01

P/E Ratio

RNTXN/A

TXTMN/A

P/S Ratio

RNTX0.00x

TXTM81,318.79x

EV/Sales

RNTX0.00x

TXTM83,093.29x

EV/EBITDA

RNTX0.00x

TXTM0.00x

P/B Ratio

RNTX1.25x

TXTMN/A

P/FCF Ratio

RNTXN/A

TXTMN/A

EV/FCF

RNTX-3.15x

TXTM-94.20x

PEG Ratio

RNTXN/A

TXTMN/A

Forward P/E (NTM)

RNTXN/A

TXTMN/A

Forward P/S (NTM)

RNTXN/A

TXTMN/A

Revenue (TTM)

RNTX$0

TXTM$800

Revenue Growth (YoY)

RNTXN/A

TXTMN/A

Forward Rev Growth

RNTX113.7%

TXTM0.0%

Gross Margin (TTM)

RNTX0.0%

TXTM87.5%

Operating Margin (TTM)

RNTX0.0%

TXTM0.0%

EBITDA Margin (TTM)

RNTX0.0%

TXTM-128712.5%

Net Margin (TTM)

RNTX0.0%

TXTM-276562.5%

FCF Margin (TTM)

RNTXN/A

TXTM-88212.5%

Net Income (TTM)

RNTX$-50M

TXTM$-2M

FCF (TTM)

RNTX$-19M

TXTM$-706K

EPS (TTM)

RNTX-$0.74

TXTM-$0.01

ROE (TTM)

RNTX-15323.0%

TXTM-940097.1%

ROA (TTM)

RNTX-11700.0%

TXTM-522856.0%

ROIC (TTM)

RNTX-14763.0%

TXTM0.0%

Cash

RNTX$9M

TXTM$700

Debt

RNTX$0

TXTM$1M

Net Cash/Debt

RNTX$9M

TXTM$-1M

Current Ratio (TTM)

RNTX4.27x

TXTM0.00x

Quick Ratio (TTM)

RNTX4.26x

TXTM0.00x

Debt/Equity (TTM)

RNTX0.00x

TXTM0.00x

Debt/Assets (TTM)

RNTX0.0%

TXTM0.0%

Interest Coverage (TTM)

RNTXN/A

TXTMN/A

Net Debt/EBITDA (TTM)

RNTX0.00x

TXTM0.00x

Beta

RNTX1.40

TXTM-3.17

52W Performance

RNTX-42.9%

TXTM184.6%

YTD Performance

RNTX-36.5%

TXTM100.0%

% from 52W High

RNTX-63.6%

TXTM-26.0%

% from 52W Low

RNTX14.4%

TXTM393.3%

Asset Turnover (TTM)

RNTX0.00x

TXTM0.04x

FCF Yield (TTM)

RNTX-27.7%

TXTM-1.1%

Earnings Yield (TTM)

RNTX-73.3%

TXTM-3.4%

Dividend Yield (TTM)

RNTXN/A

TXTMN/A

Rule of 40

RNTX0.0

TXTM-88,212.5

EV/GP/RG

RNTXN/A

TXTMN/A

Ticker research

View RNTX research View TXTM research

Metric	RNTX Rein Therapeutics Inc	TXTM Protext Mobility Inc
Market & Valuation
Market Cap	$68M	$65M
Enterprise Value	$59M	$66M
Price	$0.79	$0.01
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	81,318.79x
EV/Sales	0.00x	83,093.29x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.25x	N/A
P/FCF Ratio	N/A	N/A
EV/FCF	-3.15x	-94.20x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$800
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	113.7%	0.0%
Profitability
Gross Margin (TTM)	0.0%	87.5%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	-128712.5%
Net Margin (TTM)	0.0%	-276562.5%
FCF Margin (TTM)	N/A	-88212.5%
Net Income (TTM)	$-50M	$-2M
FCF (TTM)	$-19M	$-706K
EPS (TTM)	-$0.74	-$0.01
ROE (TTM)	-15323.0%	-940097.1%
ROA (TTM)	-11700.0%	-522856.0%
ROIC (TTM)	-14763.0%	0.0%
Financial Health
Cash	$9M	$700
Debt	$0	$1M
Net Cash/Debt	$9M	$-1M
Current Ratio (TTM)	4.27x	0.00x
Quick Ratio (TTM)	4.26x	0.00x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.40	-3.17
52W Performance	-42.9%	184.6%
YTD Performance	-36.5%	100.0%
% from 52W High	-63.6%	-26.0%
% from 52W Low	14.4%	393.3%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.04x
FCF Yield (TTM)	-27.7%	-1.1%
Earnings Yield (TTM)	-73.3%	-3.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	-88,212.5
EV/GP/RG	N/A	N/A
Ticker research	View RNTX research	View TXTM research